The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer

The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer

Abstract Objective Immunotherapy has led to changes in cervical cancer guidelines. Therefore, additional biomarkers to identify the ideal patient who would experience the most benefit may be important. Methods We retrospectively collected 208 patients with R/M CC and recorded clinicopathologic infor...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingxiu Ju, Baoyue Pan, Yongwen Huang, Yun Zhou, Jieping Chen, Huiling Xiang, Shije Xu, Siyu Chen, Chunyan Lan, Jundong Li, Min Zheng
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:Cancer Medicine
Subjects:
antiangiogenic therapy
immunotherapy
recurrent or metastatic cervical cancer
Online Access:https://doi.org/10.1002/cam4.70204
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items